Evidence map›Paper›PMID 30399512›Full record

ArticleInternational journal for parasitology. Drugs and drug resistance2018

An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.

Helen L Whiteland, Anand Chakroborty, Josephine E Forde-Thomas, Alessandra Crusco, Alan Cookson, Jackie Hollinshead, Caroline A Fenn, Barbara Bartholomew, Peter A Holdsworth, Maggie Fisher and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal for parasitology. Drugs and drug resistance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Plant-Derived Terpenes as Emerging Therapeutics Against Schistosomiasis.International journal of molecular sciences · 2026
    Review
  2. Small Molecule Ligands of the BET-like Bromodomain,Journal of medicinal chemistry · 2023
    Article
  3. Article
  4. Chemical modulation ofWellcome open research · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Drug resistance in liver flukes.International journal for parasitology. Drugs and drug resistance · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Frontiers in immunology · 2019
    Article
  17. ChronicTherapeutic advances in infectious disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Helen L WhitelandThe Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, SY23 3DA, Wales, UK. Electronic address: hew23@aber.ac.uk.
Anand ChakrobortyThe Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, SY23 3DA, Wales, UK. Electronic address: anandchakroborty@gmail.com.
Josephine E Forde-ThomasThe Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, SY23 3DA, Wales, UK. Electronic address: jef19@aber.ac.uk.
Alessandra CruscoThe Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, SY23 3DA, Wales, UK. Electronic address: alc45@aber.ac.uk.
Alan CooksonThe Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, SY23 3DA, Wales, UK. Electronic address: akc@aber.ac.uk.
Jackie HollinsheadPhytoQuest Limited, Plas Gogerddan, Aberystwyth, Ceredigion, SY23 3EB, Wales, UK. Electronic address: Jackie.hollinshead@yahoo.com.
Caroline A FennRidgeway Research Limited, Park Farm Buildings, Park Lane, St Briavels, Gloucestershire, GL15 6QX, England, UK. Electronic address: CFenn@ridgewayresearch.co.uk.
Barbara BartholomewPhytoQuest Limited, Plas Gogerddan, Aberystwyth, Ceredigion, SY23 3EB, Wales, UK. Electronic address: barbara.bartholomew@phytoquest.co.uk.
Peter A HoldsworthRidgeway Research Limited, Park Farm Buildings, Park Lane, St Briavels, Gloucestershire, GL15 6QX, England, UK. Electronic address: peter.paragon60@gmail.com.
Maggie FisherRidgeway Research Limited, Park Farm Buildings, Park Lane, St Briavels, Gloucestershire, GL15 6QX, England, UK. Electronic address: Maggie@shernacre.co.uk.
Robert J NashPhytoQuest Limited, Plas Gogerddan, Aberystwyth, Ceredigion, SY23 3EB, Wales, UK. Electronic address: robert.nash@phytoquest.co.uk.
Karl F HoffmannThe Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, SY23 3DA, Wales, UK. Electronic address: krh@aber.ac.uk.
Aberystwyth University · GBInstitute of Biological, Environmental and Rural Sciences · GB

Funding

Biotechnology and Biological Sciences Research CouncilNIAID NIH HHS HHSN272201000005I
6 · The paper itself

Abstract

Two economically and biomedically important platyhelminth species, Fasciola hepatica (liver fluke) and Schistosoma mansoni (blood fluke), are responsible for the neglected tropical diseases (NTDs) fasciolosis and schistosomiasis. Due to the absence of prophylactic vaccines, these NTDs are principally managed by the single class chemotherapies triclabendazole (F. hepatica) and praziquantel (S. mansoni). Unfortunately, liver fluke resistance to triclabendazole has been widely reported and blood fluke insensitivity/resistance to praziquantel has been observed in both laboratory settings as well as in endemic communities. Therefore, the identification of new anthelmintics is necessary for the sustainable control of these NTDs in both animal and human populations. Here, continuing our work with phytochemicals, we isolated ten triterpenoids from the mature bark of Abies species and assessed their anthelmintic activities against F. hepatica and S. mansoni larval and adult lifecycle stages. Full

Indexed as

Drug DiscoveryAbiesAnimalsAnthelminticsFasciola hepaticaFascioliasisFemaleHep G2 CellsHumansLactonesLife Cycle StagesMaleNeglected DiseasesPhytochemicalsPlant BarkSchistosoma mansoniAnthelminticsLactonesPhytochemicalsTriterpenesAbies grandisAbies proceraAnthelmintic drug discoveryFasciola hepaticaNeglected tropical diseasesSchistosoma mansoniTriterpenoid

Identifiers

PMID30399512
PMCPMC6216039
OpenAlexW2898256948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.